For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240712:nRSL1243Wa&default-theme=true
RNS Number : 1243W Helios Underwriting Plc 12 July 2024
12 July 2024
Helios Underwriting plc
("Helios" or the "Company")
Issue of Equity
Further to the announcement made on 10 July, the Company confirms that,
pursuant to the scrip dividend alternative offered in lieu of cash for the
total dividend for the year ended 31 December 2023, it has issued 164,469 new
ordinary shares of 10p each ("Ordinary Shares") in satisfaction of elections
received.
Application has been made to the London Stock Exchange for the new Ordinary
Shares, which rank pari passu with the Company's existing issued Ordinary
Shares, to be admitted to trading on AIM ('Admission'). Dealings are
expected to commence at 8.00 a.m. on 16 July 2024. Following Admission
pursuant to the scrip dividend elections received, the Company's issued share
capital will consist of 78,110,302 Ordinary Shares. The Company holds
3,200,689 Ordinary Shares in Treasury. The total number of voting rights in
the Company is therefore 74,909,613 Ordinary Shares.
For further information, please contact:
Helios Underwriting plc
Michael Wade - Chairman
Arthur Manners - Chief Financial Officer +44 (0)203
965 6441
Deutsche Numis (Nomad and Broker)
Giles Rolls / Charles
Farquhar
+44 (0)20 7260 1000
FTI Consulting
Ed Berry / Tom O'Brien
+44 (0)7703 330 199 / +44 (0)7929 021 492
About Helios
Helios provides a limited liability direct investment into the Lloyd's
insurance market and is quoted on the London Stock Exchange's AIM market
(ticker: HUW). Helios trades within the Lloyd's insurance market writing
approximately £512m of capacity for the 2024 account. The portfolio provides
a good spread of business being concentrated in property & casualty
insurance and reinsurance. For further information please visit
www.huwplc.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEFLFERDRILLIS